<DOC>
	<DOCNO>NCT02607163</DOCNO>
	<brief_summary>Acute kidney injury ( AKI ) common severe complication cardiac surgery . Postoperative AKI increase in-hospital stay , intensive care unit ( ICU ) stay postoperative mortality . Aortic surgery risky surgery cause postoperative AKI , incidence AKI aortic surgery 50 % . The α1- α2-adrenergic receptor kidney modulate vasoconstrictor vasodilatory effect , respectively . Agents attenuate renal vasoconstriction may potential renoprotective drug vasoconstriction likely contribute pathophysiology AKI . Clonidine , α2-agonist , show experimentally inhibit renin release cause diuresis , evaluate experimental AKI model , confirm potential renoprotective agent . Furthermore , already report dexmedetomidine , α2-agonist , reduce impairment renal function cardiac operation . The aim study examine association preoperative dexmedetomidine infusion incidence postoperative acute kidney injury ( AKI ) patient undergo aortic surgery .</brief_summary>
	<brief_title>The Effect Dexmedetomidine Prevention Postoperative Acute Kidney Injury Patients Undergoing Aortic Surgery</brief_title>
	<detailed_description />
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>1. patient undergoing ascend , arch and/or proximal descend aorta surgery cardiopulmonary bypass 2 . 20 100 yr old 1. preoperative severe renal dysfunction ( eGFR &lt; 15 ml/min per 1.73m2 ) 2 . Left ventricularejection fraction &lt; 30 % 3 . Preexisting congestive heart failure 4 . Severe coronary artery disease 5 . Hemodynamically unstable arrhythmia 6 . Cardiogenic shock perioperative period 7 . Ventricular assist device use 8. communication language barrier illiteracy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>